The importance of MCP-1 in the pathogenesis of pancreatic inflammation was substantiated in a study by Zhao et al. [19], where pancreatic inflammation and fibrosis was significantly reduced in rats with experimental chronic pancreatitis by giving them antichemokine gene therapy. The gene discussed is CCL2; the disease is chronic pancreatitis.